Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Back to biology: how BERG is using artificial intelligence to tackle cancer

Pharmaceutical start-up BERG is using artificial intelligence to drive its back-to-biology approach to fighting cancer. Co-founder, president and CEO Niven R. Narain talks about the start-up.

Go Top